(S)-nicotine multiple interactions EXP 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1,1-dichloroethene decreases expression EXP 6480464 vinylidene chloride results in decreased expression of ADGRL1 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of ADGRL1 mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ADGRL1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine affects expression EXP 6480464 1, 2-Dimethylhydrazine affects the expression of ADGRL1 mRNA CTD PMID:22206623 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression EXP 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions EXP 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 17alpha-ethynylestradiol decreases expression ISO RGD:620768 6480464 Ethinyl Estradiol results in decreased expression of ADGRL1 mRNA CTD PMID:17557909 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADGRL1 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:733163 6480464 Estradiol results in decreased expression of ADGRL1 mRNA CTD PMID:19167446 17beta-estradiol multiple interactions ISO RGD:620768 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of ADGRL1 mRNA CTD PMID:26496021 17beta-estradiol increases expression ISO RGD:733163 6480464 Estradiol results in increased expression of ADGRL1 mRNA CTD PMID:23019147 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADGRL1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ADGRL1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:620768 6480464 Tetrachlorodibenzodioxin results in decreased expression of ADGRL1 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:620768 6480464 Tetrachlorodibenzodioxin affects the expression of ADGRL1 mRNA CTD PMID:22298810 2-methylcholine affects expression ISO RGD:733163 6480464 beta-methylcholine affects the expression of ADGRL1 mRNA CTD PMID:21179406 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of ADGRL1 mRNA CTD PMID:26251327 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:620768 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of ADGRL1 mRNA CTD PMID:30071829 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of ADGRL1 mRNA CTD PMID:28973697 all-trans-retinoic acid decreases expression ISO RGD:733163 6480464 Tretinoin results in decreased expression of ADGRL1 mRNA CTD PMID:21934132 amphetamine decreases expression ISO RGD:620768 6480464 Amphetamine results in decreased expression of ADGRL1 mRNA CTD PMID:30779732 antirheumatic drug increases expression ISO RGD:733163 6480464 Antirheumatic Agents results in increased expression of ADGRL1 mRNA CTD PMID:24449571 arsane multiple interactions ISO RGD:733163 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ADGRL1 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:733163 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ADGRL1 mRNA CTD PMID:32525701 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of ADGRL1 mRNA CTD PMID:22228805 benzo[a]pyrene increases methylation ISO RGD:733163 6480464 Benzoapyrene results in increased methylation of ADGRL1 5' UTR CTD PMID:27901495 benzo[b]fluoranthene increases expression EXP 6480464 benzobfluoranthene results in increased expression of ADGRL1 mRNA CTD PMID:26377693 bisphenol A multiple interactions ISO RGD:620768 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of ADGRL1 mRNA CTD PMID:26496021 bisphenol A affects expression ISO RGD:620768 6480464 bisphenol A affects the expression of ADGRL1 mRNA CTD PMID:25181051 caffeine multiple interactions EXP 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 calcium atom multiple interactions ISO RGD:620768 6480464 [alpha-latrotoxin binds to ADGRL1 protein] which results in increased uptake of Calcium, [black widow spider venom binds to ADGRL1 protein] which results in increased uptake of Calcium CTD PMID:10026162 calcium(0) multiple interactions ISO RGD:620768 6480464 [alpha-latrotoxin binds to ADGRL1 protein] which results in increased uptake of Calcium, [black widow spider venom binds to ADGRL1 protein] which results in increased uptake of Calcium CTD PMID:10026162 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon results in decreased expression of ADGRL1 mRNA CTD PMID:25554681 chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of ADGRL1 mRNA CTD PMID:29980752 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of ADGRL1 mRNA CTD PMID:18353800 cisplatin decreases expression ISO RGD:733163 6480464 Cisplatin results in decreased expression of ADGRL1 mRNA CTD PMID:27392435 cocaine affects expression ISO RGD:620768 6480464 Cocaine affects the expression of ADGRL1 mRNA CTD PMID:20187946 copper atom multiple interactions ISO RGD:733163 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ADGRL1 mRNA CTD PMID:20971185 copper atom increases expression ISO RGD:620768 6480464 Copper results in increased expression of ADGRL1 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:733163 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ADGRL1 mRNA CTD PMID:20971185 copper(0) increases expression ISO RGD:620768 6480464 Copper results in increased expression of ADGRL1 mRNA CTD PMID:30556269 crocidolite asbestos increases expression EXP 6480464 Asbestos, Crocidolite results in increased expression of ADGRL1 mRNA CTD PMID:29279043 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ADGRL1 mRNA CTD PMID:17361019 , PMID:21266533 dichlorine decreases expression ISO RGD:620768 6480464 Chlorine results in decreased expression of ADGRL1 mRNA CTD PMID:18636392 dichlorine multiple interactions ISO RGD:620768 6480464 [Ozone co-treated with Chlorine] results in increased expression of ADGRL1 mRNA CTD PMID:18636392 dicrotophos increases expression ISO RGD:733163 6480464 dicrotophos results in increased expression of ADGRL1 mRNA CTD PMID:28302478 diuron increases expression ISO RGD:620768 6480464 Diuron results in increased expression of ADGRL1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:733163 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of ADGRL1 mRNA CTD PMID:27188386 doxorubicin affects response to substance ISO RGD:733163 6480464 ADGRL1 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 endosulfan decreases expression ISO RGD:620768 6480464 Endosulfan results in decreased expression of ADGRL1 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:733163 6480464 entinostat results in increased expression of ADGRL1 mRNA CTD PMID:27188386 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of ADGRL1 mRNA CTD PMID:29018328 ethanol increases expression EXP 6480464 Ethanol results in increased expression of ADGRL1 mRNA CTD PMID:30319688 folic acid multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ADGRL1 mRNA CTD PMID:22206623 L-ascorbic acid decreases expression ISO RGD:620768 6480464 Ascorbic Acid results in decreased expression of ADGRL1 mRNA CTD PMID:15372504 lead(0) affects expression ISO RGD:733163 6480464 Lead affects the expression of ADGRL1 mRNA CTD PMID:28903495 lead(0) affects splicing ISO RGD:733163 6480464 Lead affects the splicing of ADGRL1 mRNA CTD PMID:28903495 lead(2+) affects splicing ISO RGD:733163 6480464 Lead affects the splicing of ADGRL1 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:733163 6480464 Lead affects the expression of ADGRL1 mRNA CTD PMID:28903495 nicotine multiple interactions EXP 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 ozone multiple interactions ISO RGD:620768 6480464 [Ozone co-treated with Chlorine] results in increased expression of ADGRL1 mRNA CTD PMID:18636392 paracetamol decreases expression ISO RGD:733163 6480464 Acetaminophen results in decreased expression of ADGRL1 mRNA CTD PMID:22230336 paraquat affects expression ISO RGD:620768 6480464 Paraquat affects the expression of ADGRL1 mRNA CTD PMID:15493455 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of ADGRL1 mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:733163 6480464 Phenylmercuric Acetate results in decreased expression of ADGRL1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733163 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of ADGRL1 mRNA CTD PMID:27188386 SB 431542 multiple interactions ISO RGD:733163 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of ADGRL1 mRNA CTD PMID:27188386 sodium arsenate multiple interactions ISO RGD:733163 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ADGRL1 mRNA CTD PMID:32525701 sodium arsenite decreases expression ISO RGD:733163 6480464 sodium arsenite results in decreased expression of ADGRL1 mRNA CTD PMID:25879800 sulforaphane decreases expression ISO RGD:733163 6480464 sulforafan results in decreased expression of ADGRL1 mRNA CTD PMID:31838189 tetrachloromethane decreases expression ISO RGD:620768 6480464 Carbon Tetrachloride results in decreased expression of ADGRL1 mRNA CTD PMID:31150632 thioacetamide decreases expression ISO RGD:620768 6480464 Thioacetamide results in decreased expression of ADGRL1 mRNA CTD PMID:23411599 valproic acid increases expression ISO RGD:620768 6480464 Valproic Acid results in increased expression of ADGRL1 mRNA CTD PMID:23665938 valproic acid increases expression ISO RGD:733163 6480464 Valproic Acid results in increased expression of ADGRL1 mRNA CTD PMID:19101580 more ... venlafaxine hydrochloride affects expression ISO RGD:620768 6480464 Venlafaxine Hydrochloride affects the expression of ADGRL1 mRNA CTD PMID:25423262 vinclozolin affects expression ISO RGD:620768 6480464 vinclozolin affects the expression of ADGRL1 mRNA CTD PMID:19015723 zoledronic acid decreases expression ISO RGD:733163 6480464 zoledronic acid results in decreased expression of ADGRL1 mRNA CTD PMID:20977926
